Juvenile rheumatoid arthritis
Executive Summary
Draft guidelines for the clinical evaluation of anti- inflammatory and antirheumatic drugs for children were made available at the June 1 joint meeting of FDA's Arthritis and OTC Drug advisory committees. The guidelines were originally issued in 1977 and underwent minor revisions last year. The current draft updates the guidelines further with minor changes. The availability of the guidelines will be announced in a future Federal Register notice, and the Arthritis Advisory Committee will discuss them at a later meeting.